1. Home
  2. AMSS vs BCTX Comparison

AMSS vs BCTX Comparison

Compare AMSS & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMASS Brands Inc. Common Stock

AMSS

AMASS Brands Inc. Common Stock

N/A

Current Price

$0.72

Market Cap

30.6M

ML Signal

N/A

Logo BriaCell Therapeutics Corp.

BCTX

BriaCell Therapeutics Corp.

HOLD

Current Price

$4.14

Market Cap

31.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMSS
BCTX
Founded
N/A
2014
Country
United States
Canada
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.6M
31.1M
IPO Year
2026
2025

Fundamental Metrics

Financial Performance
Metric
AMSS
BCTX
Price
$0.72
$4.14
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$40.00
AVG Volume (30 Days)
74.7K
249.2K
Earning Date
N/A
06-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$380.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$2.60
52 Week High
$2.44
$14.68

Technical Indicators

Market Signals
Indicator
AMSS
BCTX
Relative Strength Index (RSI) 34.47 61.99
Support Level $0.60 $4.10
Resistance Level $1.35 $4.38
Average True Range (ATR) 0.05 0.20
MACD 0.01 0.06
Stochastic Oscillator 27.92 71.52

Price Performance

Historical Comparison
AMSS
BCTX

About AMSS AMASS Brands Inc. Common Stock

Amass Brands Inc is building a diversified premium beverage platform at the intersection of craft, wellness, and functionality. The company operates in the beverage industry, offering a portfolio that includes spirits, wine, and non-alcoholic products. The company distributes its brands in the United States through wholesale, on-premise, and direct-to-consumer channels. The company has two segments: Wine and Spirits. The majority of the company's revenue is derived from the Wine segment, which offers a portfolio of premium imported and domestic wine brands. Geographically, it operates predominantly in the USA.

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Share on Social Networks: